For example, two pan-cancer studies have shown that TERT promoter mutations are present in at least six cancer types including glioblastoma, bladder, low-grade glioma, melanoma, and lung (and liver which is analyzed in one of the studies) [68, 94]. Here, TERT is linked to central nervous system cancer.